Clinical Trial Update: A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets [Phase 1]

View source ↗

Summary

A Phase 1 study compared two dose strengths of CVT-301 levodopa inhalation powder with Sinemet (carbidopa-levodopa) tablets in Parkinson's disease; the trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CVT-301 (levodopa inhalation powder)
• SINEMET (carbidopa and levodopa)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED